4.1083
price down icon7.03%   -0.3017
 
loading

Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
87.59%
94.97
50.63 50.87 61.76 49.37
Operating Income/Loss
87.59%
-94.97
-50.63 -50.87 -61.76 -49.37
Income/Loss From Continuing Operations Before Tax
89.92%
-93.80
-49.39 -49.07 -59.92 -50.29
Income/Loss From Continuing Operations After Tax
89.92%
-93.80
-49.39 -49.07 -59.92 -50.29
Net Income/Loss
89.92%
-93.80
-49.39 -49.07 -59.92 -50.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.35%
238.41
237.58 1.815 235.41 234.44
Diluted Average Shares
0.35%
238.41
237.58 1.815 235.41 234.44
Basic Earnings Per Share
85.71%
-0.39
-0.21 -0.21 -0.25 -0.21
Diluted Earnings Per Share
85.71%
-0.39
-0.21 -0.21 -0.25 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$43.65
price up icon 1.58%
$31.83
price down icon 3.60%
$102.22
price up icon 1.30%
$108.72
price up icon 0.39%
$151.64
price down icon 3.67%
biotechnology ONC
$349.18
price up icon 0.77%
Kapitalisierung:     |  Volumen (24h):